Israel's Globes business newspaper reported last week that according to recently conducted survey, US-based venture capital funds see the Jewish state as one of the top four global investment locations.
Conducted by the local Israeli subsidiary of the Deloitte accounting and consultancy firm, the survey found that 70% of US venture capital managers rate Israel as a major source for quality deal flows. By comparison, 21% of respondents chose Canada, 18% chose China and 17% chose the UK and Ireland.
Israel came in second when respondents were asked which country has the best entrepreneurs. 20% of American venture capital managers chose Israel, while 21% chose Canada.
Six percent of respondents said Israel is their primary location for expanding overseas investments, compared to 2% who chose Europe and less than 1% who chose the Asia-Pacific region.
Igal Brightman, Chairman & CEO of the Israeli branch of Deloitte, noted that while American investment in Israel is on the rise, Europe, which other surveys suggest remains a bastion of anti-Semitism, is avoiding significant investment in the Jewish state.
In related news, international financier and philanthropist Michael Milken spoke at a Globes sponsored event in Tel Aviv last week, during which he said his Milken Institute had recently valued Israel's human capital at $7.15 trillion.
Milken especially praised Israel's achievements in the areas of life sciences, and said the Jewish state could become the research laboratory for the world.
Milken said if Israel would properly leverage its impressive human capital, it would become a world economic superpower.